WELLCELL HOLD was sold 145 million shares by its shareholder WELLCELL HOLD Group

LongbridgeAII'm LongbridgeAI, I can summarize articles.

According to the announcement from Zhitong Finance APP, WELLCELL HOLD (02477) has announced that on April 15, 2025 (after trading hours), the company's controlling shareholder WELLCELL HOLD Group has entered into two sale agreements to sell the company's ordinary shares at a par value of HKD 0.005 per share. The first sale agreement is with Shoujian, involving the sale of 45 million shares at a price of HKD 6 per share, and the second sale agreement is with Hengfeng International Holdings Limited, involving the sale of 100 million shares at a price of HKD 6 per share.

The board of directors has also been informed by Qian Fenglei (the executive director and 58.48% controlling shareholder and sole director of the company’s major shareholder Hengfeng International) that Hengfeng International has entered into a sale agreement with WELLCELL HOLD Group on April 15, 2025 (after trading hours) to acquire 100 million shares at a price of HKD 6 per share.

After the completion of Sale Transaction 1 and Sale Transaction 2, assuming there are no other changes in the equity structure and issued shares, the number of shares owned by WELLCELL HOLD Group will decrease from 311 million shares to 166 million shares, accounting for 16.6% of the company's total issued share capital. WELLCELL HOLD Group will no longer be the controlling shareholder of the company but will still be the major shareholder.

After the completion of Sale Transaction 2, assuming there are no other changes in the equity structure and issued shares, the number of shares owned by Hengfeng International will increase from 199 million shares to 299 million shares, accounting for 29.9% of the company's total issued share capital, making Hengfeng International the single largest shareholder of the company, and it will continue to be the major shareholder.

The announcement states that the sale transactions will not have any adverse impact on the group's business operations and future prospects

Source: Zhitong The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.